Prediction of Asthma Exacerbations in Children

Evangelia Sarikloglou1, Sotirios Fouzas2, Emmanouil Paraskakis3

  • 1Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

PubMed

Insights

Identifying children at risk for asthma exacerbations is crucial for preventing serious events. Factors like age, clinical history, and environmental exposures predict future asthma attacks in pediatric patients.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Asthma exacerbations are frequent in children, impacting daily life and leading to severe outcomes.
  • Early identification of high-risk pediatric asthma patients is essential for proactive management.

Purpose of the Study:

  • To review predictors of asthma exacerbations in children.
  • To provide guidance for monitoring at-risk pediatric asthma patients.

Main Methods:

  • Literature review of existing evidence on asthma exacerbation predictors.
  • Analysis of demographic, clinical, inflammatory, and environmental factors.

Main Results:

  • Asthma exacerbation risk is influenced by a heterogeneous group of factors.
  • Key predictors include younger age, prior exacerbations, poor asthma control, comorbidities, Th2 inflammation, and environmental exposures.

Conclusions:

  • Prompt recognition of at-risk children is vital for preventing asthma attacks.
  • Comprehensive monitoring considering multiple risk factors is recommended for pediatric asthma management.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299